The US National Cancer Institute (NCI) will provide specialist trial group Cancer Research for the Ozarks (CRO) with a $4.2m grant to support its clinical programme.
The funding, which will be rolled out over a five year period, is designed to improve CRO’s ability to match suitable cancer patients with trial programmes being run by key collaborators like the Cox Health and St John’s hospital groups.
The grant, which is equivalent to 80 per cent of the funding required by CRO, will be supported by contributions from both Cox Health and St John’s
CRO’s director Marilyn Bauer told New-Leader.com that: “We’re pleased that in a time when a lot of people aren't getting funded, we did. And that really speaks to the quality of our program.”